CapEdge
Loading...
Advanced
What's new? Log in Free sign up
  • Home
  • Sectors & IndustriesSectors
  • Earnings
  • IPOs
  • SPACs
  • Transcripts
  • Insider
  • Institutional
  • Crypto
  • Screeners
  • Reddit
  • Splits
  • ELV Dashboard
  • Financials
  • Filings
  • Transcripts
  • ETFs
  • Insider
  • Institutional
  • Shorts
  • News
  • Patents
  • Reddit

Elevance Health (ELV)

Company Profile
Anthem is a leading health benefits company dedicated to improving lives and communities, and making healthcare simpler. Through its affiliated companies, Anthem serves more than 110 million people, including approximately 43 million within its family of health plans. We aim to be the most innovative, valuable and inclusive partner.
Elevance Health logo

Company profile

Ticker
ELV
Exchange
NYSE
Website
www.antheminc.com
CEO
Gail Boudreaux
Employees
Incorporated
Indiana
Location
Indiana
Fiscal year end
Dec 31
Sector
Finance and Insurance > Direct Health and Medical Insurance Carriers
Industry (SIC)
Hospital & Medical Service Plans
Unitedhealth • Cigna • Humana • Oscar Health • Molina Healthcare • Bright Health • Clover Health Investments • Alignment Healthcare • Trupanion • Centene ...
Former names
ANTHEM INC, Anthem, Inc., WELLPOINT INC, WELLPOINT, INC
SEC CIK
0001156039
Corporate docs
Articles of Incorporation & Bylaws
Underwriting Agreements
Plans of Reorganization
Indentures
Material Contracts & Credit Agreements
Subsidiaries Lists
Subsidiaries
Advantage Medical Group, LLC • Alianza Medicos del SurEste, LLC • Alliance Care Management, LLC • American Imaging Management, Inc. • AMERIGROUP Community Care of New Mexico, Inc. • AMERIGROUP Corporation • Amerigroup Delaware, Inc. • Amerigroup District of Columbia, Inc. • Amerigroup Insurance Company • Amerigroup Iowa, Inc. ...
IRS number
352145715

ELV stock data

Analyst ratings and price targets

Last 3 months
Current price
Average target
$569.00
Low target
$523.00
High target
$609.00
RBC Capital
Maintains
Sector Perform
$523.00
26 Jan 23
Wells Fargo
Maintains
Overweight
$609.00
4 Jan 23
Mizuho
Maintains
Buy
$575.00
10 Nov 22
Latest filings (excl ownership)
View all
8-K
Other Events
8 Feb 23
424B3
Prospectus supplement
31 Jan 23
FWP
Free writing prospectus
30 Jan 23
424B3
Prospectus supplement
30 Jan 23
8-K
Elevance Health Reports Fourth Quarter
25 Jan 23
8-K
Other Events
4 Nov 22
424B3
Prospectus supplement
27 Oct 22
FWP
Free writing prospectus
26 Oct 22
424B3
Prospectus supplement
26 Oct 22
8-K
Departure of Directors or Certain Officers
25 Oct 22
Transcripts
View all
ELV
Earnings call transcript
2022 Q4
25 Jan 23
ELV
Earnings call transcript
2022 Q3
19 Oct 22
ELV
Earnings call transcript
2022 Q2
20 Jul 22
ELV
Earnings call transcript
2022 Q1
20 Apr 22
ELV
Earnings call transcript
2021 Q4
26 Jan 22
ELV
Earnings call transcript
2021 Q3
20 Oct 21
ELV
Earnings call transcript
2021 Q2
21 Jul 21
ELV
Earnings call transcript
2021 Q1
21 Apr 21
ELV
Earnings call transcript
2020 Q4
27 Jan 21
ELV
Earnings call transcript
2020 Q3
28 Oct 20
Latest ownership filings
View all
SC 13G/A
BlackRock Inc.
27 Jan 23
SC 13G/A
BlackRock Inc.
25 Jan 23
4
Blair Williams Todt
5 Jan 23
4
Felicia F Norwood
4 Jan 23
4
Blair Williams Todt
5 Dec 22
SC 13G
GoHealth, Inc.
15 Nov 22
4
GAIL BOUDREAUX
4 Nov 22
4
Charles Morgan Kendrick JR
3 Nov 22
4
Peter D Haytaian
3 Nov 22
4
DEANNA D STRABLE-SOETHOUT
2 Nov 22

Financial summary

Financial statements Chart ELV financial data
Quarter (USD) Sep 22 Jun 22 Mar 22 Dec 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD) Dec 21 Dec 20 Dec 19 Dec 18
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Financial data from company earnings reports.

Institutional ownership, Q3 2022

ELV institutional ownership history Ownership history
83.1% owned by funds/institutions
13F holders Current Prev Q Change
Total holders 1401 1407 -0.4%
Opened positions 105 131 -19.8%
Closed positions 111 113 -1.8%
Increased positions 552 511 +8.0%
Reduced positions 479 504 -5.0%
13F shares Current Prev Q Change
Total value 90.62 bn 101.65 bn -10.9%
Total shares 199.36 mm 210.71 mm -5.4%
Total puts 1.26 mm 1.08 mm +16.7%
Total calls 1.16 mm 988.30 k +17.6%
Total put/call ratio 1.1 1.1 -0.8%
Largest owners Shares Value Change
Vanguard 21.23 mm $9.65 bn +0.9%
BLK Blackrock 21.05 mm $9.56 bn -3.3%
T. Rowe Price 10.75 mm $4.88 bn +13.6%
Wellington Management 9.20 mm $4.18 bn -6.6%
Capital International Investors 6.67 mm $3.03 bn +3.9%
FMR 6.52 mm $2.96 bn -0.4%
Geode Capital Management 4.21 mm $1.91 bn +1.8%
BAC Bank Of America 4.18 mm $1.90 bn -10.4%
Baillie Gifford & Co 3.97 mm $1.81 bn -2.2%
Sanders Capital 3.96 mm $1.80 bn -2.8%
Largest transactions Shares Bought/sold Change
STT State Street 0.00 -10.84 mm EXIT
T. Rowe Price 10.75 mm +1.29 mm +13.6%
Viking Global Investors 2.34 mm +872.36 k +59.6%
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main 66.71 k -734.71 k -91.7%
BLK Blackrock 21.05 mm -722.80 k -3.3%
Wellington Management 9.20 mm -646.79 k -6.6%
Voya Investment Management 640.96 k +509.21 k +386.5%
BAC Bank Of America 4.18 mm -483.23 k -10.4%
Amundi 1.31 mm +462.78 k +54.4%
Steadfast Capital Management 135.44 k -448.53 k -76.8%
Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

ELV insider ownership history Insider history
Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
3 Jan 23 Blair Williams Todt Common Stock Grant Acquire A No No 0 3,983 0.00 8,283
30 Dec 22 Felicia F Norwood Common Stock Payment of exercise Dispose F No No 512.97 1,754 899.75 k 26,684
1 Dec 22 Blair Williams Todt Common Stock Payment of exercise Dispose F No No 525.25 117 61.45 k 4,300
4 Nov 22 Gail Boudreaux Common Stock Gift Dispose G No No 0 10,000 0.00 111,415
Data from 3, 4 and 5 filings. Values as filed, not updated for current price.

News

From Benzinga Pro
Here's How Much $100 Invested In Elevance Health 5 Years Ago Would Be Worth Today
30 Jan 23
RBC Capital Maintains Sector Perform on Elevance Health, Raises Price Target to $523
26 Jan 23
RBC Capital analyst Ben Hendrix maintains Elevance Health (NYSE:ELV) with a Sector Perform and raises the price target from $505 to $523.
SVB Leerink Reiterates Outperform on Elevance Health, Maintains $580 Price Target
26 Jan 23
SVB Leerink analyst Whit Mayo reiterates Elevance Health (NYSE:ELV) with a Outperform and maintains $580 price target.
Elevance Health Q4 EPS $5.23 Beats $5.19 Estimate, Sales $39.67B Miss $39.76B Estimate
25 Jan 23
Earnings Scheduled For January 25, 2023
25 Jan 23

Press releases

From Benzinga Pro
Thinking about trading options or stock in Visa, Autoliv, Electronic Arts, Elevance Health, or Microsoft?
27 Jan 23
NEW YORK, Jan. 27, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for V, ALV, EA, ELV, and MSFT.
Elevance Health's 2.750% Senior Convertible Debentures due 2042 to Accrue Contingent Interest
25 Jan 23
Elevance Health, Inc. (NYSE:ELV) announced today that for the six-month interest period commencing on October 15, 2022, its 2.750% Senior Convertible Debentures due 2042 (the "Debentures") will accrue contingent
Elevance Health Reports Fourth Quarter and Full Year 2022 Results
25 Jan 23
Fourth quarter and full year GAAP net income was $3.93 and $24.81 per share Fourth quarter and full year adjusted net income was $5.23* and $29.07* per share Full year operating revenue grew 13.7%
AM Best Comments on Credit Ratings of Elevance Health, Inc. and Its Subsidiaries Following Acquisition Announcement
24 Jan 23
Elevance Health to Acquire Blue Cross and Blue Shield of Louisiana
23 Jan 23
Finsight
Resources
  • Knowledgebase
  • Log In
  • Register
Company
  • About
  • Contact
  • Solutions
Products
  • Deal Roadshow
  • DealVDR
  • Evercall
  • Finsight.com
CapEdge
  • Earnings Calendar
  • Earnings Transcripts
  • EDGAR Filing Screener
  • IPO Calendar
  • Compliance
  • Privacy
  • Security
  • Terms
AngelList LinkedIn